Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Combined in silico and in vitro Approach to Drug Screening (CROSBI ID 115159)

Prilog u časopisu | stručni rad

Verbanac, Donatella ; Jelić, Dubravko ; Stepanić, Višnja ; Tatić, Iva ; Žiher, Dinko ; Koštrun, Sanja Combined in silico and in vitro Approach to Drug Screening // Croatica chemica acta, 78 (2005), 2; 133-139

Podaci o odgovornosti

Verbanac, Donatella ; Jelić, Dubravko ; Stepanić, Višnja ; Tatić, Iva ; Žiher, Dinko ; Koštrun, Sanja

engleski

Combined in silico and in vitro Approach to Drug Screening

The purpose of High Throughput Screening (HTS) in pharmaceutical industry is to discover compounds that are good starting points for drug discovery. Experts from this area study the chemical structures of so called "hit" compounds that have been found to interact with the target protein, interfere with proliferation of different types of cells or disable of bacterial or fungal growth. Hypotheses to design related structures with improved biological properties are than builded. Each idea is then tested by the iterative synthesis and testing of novel compounds in various biological assays, searching for hits with better properties and defining useful and promising "lead" molecules. In parallel, molecular modeling and chemoinformatics experts can increase efficiency and decrease experimental costs by using different database filtering methods. In such a way, hits from HTS may be assessed before committing significant resource for chemical optimization. Joint efforts of these HTS experimental and modeling groups are the best way to speed up the process of finding a new useful hits and promising leads.

clustering ; compounds library ; drug discovery ; in silico ; in vitro ; screening

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

78 (2)

2005.

133-139

objavljeno

0011-1643

Povezanost rada

Temeljne medicinske znanosti, Farmacija

Poveznice
Indeksiranost